Article Information
vol. 61 no. 4
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 9, 2022
- Accepted December 22, 2022
- Published online April 20, 2023.
Article Versions
- previous version (January 26, 2023 - 07:49).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Anna J. Podolanczuk1,
- Carey C. Thomson2,
- Martine Remy-Jardin3,
- Luca Richeldi4,
- Fernando J. Martinez1,
- Martin Kolb5 and
- Ganesh Raghu6⇑
- 1Department of Medicine, Weill Cornell Medical College, New York, NY, USA
- 2Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Harvard Medical School, Boston, MA, USA
- 3Department of Thoracic Imaging, University of Lille, Lille, France
- 4Division of Pulmonary Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
- 5Department of Respiratory Medicine, Pathology and Molecular Medicine, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada
- 6Department of Medicine and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
- Corresponding author: Ganesh Raghu (graghu{at}uw.edu)
Article usage
Altmetrics
Vol 61 Issue 4
Table of Contents
Idiopathic pulmonary fibrosis: state of the art for 2023
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Diagnosis of IPF
- Incidence and prevalence
- Risk factors for IPF
- Early detection and screening
- Natural history of IPF
- Acute exacerbation of IPF
- Comorbidities
- Treatment of IPF
- Monitoring for disease progression
- Biomarkers
- Morbidity and mortality
- Summary and future directions
- Supplementary material
- Shareable PDF
- Footnotes
- References
- Figures & Data
- Info & Metrics